Smithbridge Asset Management Inc Abbott Laboratories Transaction History

Smithbridge Asset Management Inc

  • $483 Million
  • Q1 2024

A detailed history of Smithbridge Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 44,877 shares of ABT stock, worth $4.59 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
44,877
Previous 44,998 0.27%
Holding current value
$4.59 Million
Previous $4.95 Million 2.97%
% of portfolio
1.06%
Previous 1.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$109.52 - $120.96 $13,251 - $14,636
-121 Reduced 0.27%
44,877 $5.1 Million
Q4 2023

Jan 18, 2024
SELL
$90.19 - $110.4 $35,625 - $43,608
-395 Reduced 0.87%
44,998 $4.95 Million
Q3 2023

Oct 25, 2023
BUY
$95.53 - $114.62 $49,006 - $58,800
513 Added 1.14%
45,393 $4.4 Million
Q2 2023

Jul 20, 2023
BUY
$100.78 - $112.29 $55,328 - $61,647
549 Added 1.24%
44,880 $4.89 Million
Q2 2023

Jul 18, 2023
SELL
$100.78 - $112.29 $31,141 - $34,697
-309 Reduced 0.69%
44,331 $4.87 Million
Q1 2023

Apr 20, 2023
BUY
$96.86 - $114.01 $29,929 - $35,229
309 Added 0.7%
44,640 $4.52 Million
Q4 2022

Mar 01, 2023
BUY
$95.06 - $111.52 $47,530 - $55,760
500 Added 1.14%
44,331 $4.87 Million
Q3 2022

Oct 25, 2022
BUY
$96.76 - $112.03 $61,732 - $71,475
638 Added 1.48%
43,831 $4.24 Million
Q2 2022

Aug 03, 2022
SELL
$102.07 - $123.37 $2,041 - $2,467
-20 Reduced 0.05%
43,193 $4.69 Million
Q1 2022

Apr 25, 2022
SELL
$114.02 - $139.04 $14,024 - $17,101
-123 Reduced 0.28%
43,213 $5.12 Million
Q4 2021

Jan 24, 2022
BUY
$115.53 - $141.46 $38,009 - $46,540
329 Added 0.76%
43,336 $6.1 Million
Q3 2021

Oct 04, 2021
SELL
$116.66 - $129.06 $47,947 - $53,043
-411 Reduced 0.95%
43,007 $5.08 Million
Q2 2021

Jul 23, 2021
BUY
$105.79 - $124.53 $95,211 - $112,077
900 Added 2.12%
43,418 $5.03 Million
Q1 2021

Apr 06, 2021
BUY
$108.84 - $128.23 $132,784 - $156,440
1,220 Added 2.95%
42,518 $5.1 Million
Q4 2020

Jan 21, 2021
SELL
$105.0 - $114.42 $117,390 - $127,921
-1,118 Reduced 2.64%
41,298 $4.52 Million
Q3 2020

Oct 29, 2020
BUY
$91.64 - $111.29 $14,570 - $17,695
159 Added 0.38%
42,416 $4.62 Million
Q2 2020

Jul 01, 2020
BUY
$76.57 - $98.0 $76,570 - $98,000
1,000 Added 2.42%
42,257 $3.86 Million
Q1 2020

Apr 13, 2020
SELL
$62.82 - $91.86 $47,806 - $69,905
-761 Reduced 1.81%
41,257 $3.26 Million
Q4 2019

Jan 09, 2020
SELL
$78.51 - $87.4 $45,928 - $51,129
-585 Reduced 1.37%
42,018 $3.65 Million
Q3 2019

Oct 15, 2019
BUY
$81.84 - $88.74 $31,917 - $34,608
390 Added 0.92%
42,603 $3.57 Million
Q2 2019

Jul 09, 2019
BUY
$72.88 - $85.0 $364 - $425
5 Added 0.01%
42,213 $3.55 Million
Q1 2019

Apr 03, 2019
BUY
$66.22 - $80.06 $33,441 - $40,430
505 Added 1.21%
42,208 $3.37 Million
Q4 2018

Jan 15, 2019
SELL
$65.56 - $74.27 $23,470 - $26,588
-358 Reduced 0.85%
41,703 $3.02 Million
Q3 2018

Oct 05, 2018
BUY
$60.81 - $73.36 $96,687 - $116,642
1,590 Added 3.93%
42,061 $3.09 Million
Q2 2018

Jul 18, 2018
SELL
$57.57 - $63.54 $56,706 - $62,586
-985 Reduced 2.38%
40,471 $2.47 Million
Q1 2018

Apr 09, 2018
SELL
$56.27 - $63.62 $82,829 - $93,648
-1,472 Reduced 3.43%
41,456 $2.48 Million
Q4 2017

Jan 18, 2018
BUY
$53.68 - $57.47 $39,293 - $42,068
732 Added 1.73%
42,928 $2.45 Million
Q3 2017

Oct 12, 2017
BUY
$48.06 - $53.64 $2.03 Million - $2.26 Million
42,196
42,196 $2.25 Million

Others Institutions Holding ABT

# of Institutions
3,124
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Smithbridge Asset Management Inc Portfolio

Follow Smithbridge Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email